See the Shortlisted Nominees for the 13th World ADC Awards
The votes have been counted, and we are delighted to share the 2026 shortlisted nominees who will prepare and submit proposals for the judge’s consideration.
Best ADC Platform Technology
Shortlisted:
- AJICAP – Ajinomoto Bio-Pharma Services
- ConjuAll – LigaChem Biosciences
- GlycoConnect – Lonza
- TMALIN – MediLink Therapeutics
- WuXi DARx – WuXi XDC
Best New ADC Drug Developer
Shortlisted:
- Aarvik Therapeutics
- Callio Therapeutics
- Firefly Bio
- Kivu Bioscience
- Valink Therapeutics
Most Promising ADC to Watch
Shortlisted:
- DS3939a – Daiichi Sankyo
- Emiltatug ledadotin (Emi-Le) – Mersana Therapeutics/Servier
- JK06 – Salubris Biotherapeutics
- Mocertatug rezetecan (Mo-Rez) – GSK & Hansoh Pharma
- Puxitatug samrotecan – AstraZeneca
- Sofetabart mipitecan – Eli Lilly
- TUB-040 – Tubulis/Gilead
Best ADC Clinical Impact
Shortlisted:
- Belantamab mafodotin (Blenrep) – GSK
- Izalontamab brengitecan (Iza-bren) – BMS & SystImmune
- Pivekimab Sunirine (Decnupaz) – AbbVie
- HER3-DXd – Daiichi Sankyo & Merck
- IKS014 – Iksuda Therapeutics & Fosun Pharma
Best CDMO
Shortlisted:
- Abzena
- Asymbio
- Axplora
- BSP Pharmaceuticals
- Lonza
- MilliporeSigma
- Piramal Pharma Solutions
- WuXi XDC
Best CRO
Shortlisted:
- Charles River
- ChemExpress
- Crown Biosciences
- ICON
- NJ Bio
- WuXi XDC
Best Up & Coming Solution Provider
Shortlisted:
- HUB Organoids
- LIDE Biotech
- LOTTE Biologics
- Sygnature Discovery
- Turbine
- Xcellon
Explore World ADC San Diego's Agenda
Discover the latest industry breakthroughs and insights to be shared at the biggest ADC event, ahead of the awards' gala.
Partner With Us
Position yourself in front of the pioneers trailblazing ADCs to standard of care treatments.
View the 2025 Shortlisted
Have a look at the shortlisted candidates to be recognized this year because of their exceptional work propelling the ADC field to new heights.